Featured Research

from universities, journals, and other organizations

Scientists Use Salmonella To Fight Cancer In First Human Trials

Date:
December 13, 1999
Source:
Yale University
Summary:
A genetically engineered strain of the bacteria Salmonella has been administered to the first cancer patients enrolled in a Phase I intratumoral clinical trial. The concept, developed by Yale Cancer Center researchers and licensed to Vion Pharmaceuticals in New Haven, Conn., involves the use of engineered strains of the common Salmonella bacterium, the same bacterium that, in its unaltered or wild type form, can cause food poisoning and septic shock.

(NEW HAVEN) -- A genetically engineered strain of the bacteria Salmonella has been administered to the first cancer patients enrolled in a Phase I intratumoral clinical trial. The patients were initially monitored in the hospital and subsequently discharged.

Related Articles


The concept, developed by Yale Cancer Center researchers and licensed to Vion Pharmaceuticals in New Haven, Conn., involves the use of engineered strains of the common Salmonella bacterium, the same bacterium that, in its unaltered or wild type form, can cause food poisoning and septic shock. The altered Salmonella, stripped of its pathogenicity, has been shown to target solid tumors and inhibit their growth in laboratory animals.

The key is that the safe versions are still able to target solid tumors in laboratory animals, much like the wild type parent, while at the same time have little or no adverse effects. "We have shown that we can significantly prolong the life of mice with melanoma by injecting them with our attenuated bacteria," said John M. Pawelek, Ph.D., senior research scientist in dermatology and a lecturer in pharmacology at the Yale University School of Medicine. "These preliminary results with animals are encouraging. We would now like to see the same outcome in people."

Collaborating with Pawelek on this novel approach to fighting cancer are K. Brooks Low, Ph.D., a bacterial geneticist and professor of research in therapeutic radiology at Yale, and former Yale colleague David Bermudes, Ph.D., now a senior scientist working on the Salmonella project at Vion.

Potential safety and efficacy will continue to be monitored according to the protocol. The study is designed to evaluate the safety, potential efficacy and optimum biological dose of the bacterial vector for patients with either cutaneous or subcutaneous solid tumors. Patient accrual for the trial is continuing.

###

The Yale Cancer Center is one of a select network of comprehensive cancer centers in the country designated by the National Cancer Institute and the only one in Southern New England. Bringing together the resources of Yale-New Haven Hospital and the Yale University School of Medicine, its mission encompasses patient care, research, cancer prevention and control, community outreach and education.


Story Source:

The above story is based on materials provided by Yale University. Note: Materials may be edited for content and length.


Cite This Page:

Yale University. "Scientists Use Salmonella To Fight Cancer In First Human Trials." ScienceDaily. ScienceDaily, 13 December 1999. <www.sciencedaily.com/releases/1999/12/991213051204.htm>.
Yale University. (1999, December 13). Scientists Use Salmonella To Fight Cancer In First Human Trials. ScienceDaily. Retrieved December 20, 2014 from www.sciencedaily.com/releases/1999/12/991213051204.htm
Yale University. "Scientists Use Salmonella To Fight Cancer In First Human Trials." ScienceDaily. www.sciencedaily.com/releases/1999/12/991213051204.htm (accessed December 20, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, December 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

The Best Tips to Curb Holiday Carbs

The Best Tips to Curb Holiday Carbs

Buzz60 (Dec. 19, 2014) It's hard to resist those delicious but fattening carbs we all crave during the winter months, but there are some ways to stay satisfied without consuming the extra calories. Vanessa Freeman (@VanessaFreeTV) has the details. Video provided by Buzz60
Powered by NewsLook.com
Sierra Leone Bikers Spread the Message to Fight Ebola

Sierra Leone Bikers Spread the Message to Fight Ebola

AFP (Dec. 19, 2014) More than 100 motorcyclists hit the road to spread awareness messages about Ebola. Nearly 7,000 people have now died from the virus, almost all of them in west Africa, according to the World Health Organization. Video provided by AFP
Powered by NewsLook.com
Researchers Test Colombian Village With High Alzheimer's Rates

Researchers Test Colombian Village With High Alzheimer's Rates

AFP (Dec. 19, 2014) In Yarumal, a village in N. Colombia, Alzheimer's has ravaged a disproportionately large number of families. A genetic "curse" that may pave the way for research on how to treat the disease that claims a new victim every four seconds. Duration: 02:42 Video provided by AFP
Powered by NewsLook.com
Double-Amputee Becomes First To Move Two Prosthetic Arms With His Mind

Double-Amputee Becomes First To Move Two Prosthetic Arms With His Mind

Buzz60 (Dec. 19, 2014) A double-amputee makes history by becoming the first person to wear and operate two prosthetic arms using only his mind. Jen Markham has the story. Video provided by Buzz60
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins